{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"acute-megakaryoblastic-leukemia","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"A rare acute myeloid leukemia that occurs predominantly in childhood and particularly in children with Down syndrome (DS-AMKL). Nonspecific symptoms may be irritability, weakness, and dizziness while specific symptoms include pallor, fever, mucocutaneous bleeding, hepatosplenomegaly, neurological manifestations and rarely lymphadenopathy. Acute panmyelosis with myelofibrosis may also be associated with AMKL. In contrast to DS-AMKL (around 80 % survival), non-DS-AMKL is an AML subgroup associated with poor prognosis.","mondoId":"MONDO:0018872","node":{"canonicalSlug":"acute-megakaryoblastic-leukemia","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Acute megakaryoblastic leukemia","originalSourceId":"ORPHA:518","paragraphs":["A rare acute myeloid leukemia that occurs predominantly in childhood and particularly in children with Down syndrome (DS-AMKL). Nonspecific symptoms may be irritability, weakness, and dizziness while specific symptoms include pallor, fever, mucocutaneous bleeding, hepatosplenomegaly, neurological manifestations and rarely lymphadenopathy. Acute panmyelosis with myelofibrosis may also be associated with AMKL. In contrast to DS-AMKL (around 80 % survival), non-DS-AMKL is an AML subgroup associated with poor prognosis."],"rawAttribution":"MONDO:0018872","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:38:17Z","upstream":"MONDO:0018872","url":"https://rarediseases.info.nih.gov/diseases/524"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"acute myeloid leukemia by FAB classification","mondoId":"MONDO:0015667","slug":"acute-myeloid-leukemia-by-fab-classification"},{"kind":"child","label":"acute megakaryoblastic leukemia without down syndrome","mondoId":"MONDO:0018004","slug":null},{"kind":"child","label":"acute megakaryoblastic leukemia in down syndrome","mondoId":"MONDO:0020526","slug":null},{"kind":"child","label":"childhood acute megakaryoblastic leukemia","mondoId":"MONDO:0850267","slug":"childhood-acute-megakaryoblastic-leukemia"},{"kind":"child","label":"myeloid leukemia associated with down syndrome","mondoId":"MONDO:0850271","slug":"myeloid-leukemia-associated-with-down"},{"kind":"child","label":"acute megakaryoblastic leukemia in adult","mondoId":"MONDO:0971091","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/524\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0018872\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0018872</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare acute myeloid leukemia that occurs predominantly in childhood and particularly in children with Down syndrome (DS-AMKL). Nonspecific symptoms may be irritability, weakness, and dizziness while specific symptoms include pallor, fever, mucocutaneous bleeding, hepatosplenomegaly, neurological manifestations and rarely lymphadenopathy. Acute panmyelosis with myelofibrosis may also be associated with AMKL. In contrast to DS-AMKL (around 80 % survival), non-DS-AMKL is an AML subgroup associated with poor prognosis.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/524\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"acute-megakaryoblastic-leukemia","sourceDocuments":[{"name":"GARD: Acute megakaryoblastic leukemia","reviewed":null,"source_release":"2026-10-25T03:38:17Z","url":"https://rarediseases.info.nih.gov/diseases/524"},{"name":"MONDO: acute megakaryoblastic leukemia","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0018872"}],"sourceNote":"","synonyms":["acute M7 myeloid leukaemia","acute M7 myeloid leukemia","acute megakaryoblastic leukaemia (FAB type M7)","acute megakaryoblastic leukemia","acute megakaryoblastic leukemia (FAB type M7)","acute megakaryoblastic leukemia, FAB M7","acute megakaryocytic leukaemia","acute megakaryocytic leukemia","acute megakaryocytic leukemias","acute myeloblastic leukaemia type 7","acute myeloblastic leukemia type 7","acute myeloid leukaemia M7","acute myeloid leukemia M7","AMKL","AML M7","FAB M7","leukemia, megakaryocytic, malignant","megakaryocytic leukaemia","thrombocytic leukemia"],"takeawayHtml":"","title":"acute megakaryoblastic leukemia"},"schemaVersion":1}
